Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : email@example.com
|Title||Ramucirumab and Atezolizumab After Progression on Any Immune Checkpoint Blocker in NSCLC (RamAtezo-1)|
|Recruitment||Active, not recruiting|
|Sponsors||Washington University School of Medicine|
|Age Groups:||adult | senior|